.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Deloitte
Healthtrust
US Department of Justice
Cerilliant
Express Scripts
Queensland Health
AstraZeneca
Boehringer Ingelheim

Generated: September 24, 2017

DrugPatentWatch Database Preview

AZACTAM IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Azactam In Plastic Container, and what generic Azactam In Plastic Container alternatives are available?

Azactam In Plastic Container is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in AZACTAM IN PLASTIC CONTAINER is aztreonam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aztreonam profile page.

Summary for Tradename: AZACTAM IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list4
Clinical Trials: see list467
Patent Applications: see list5,389
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AZACTAM IN PLASTIC CONTAINER at DailyMed

Pharmacology for Tradename: AZACTAM IN PLASTIC CONTAINER

Ingredient-typeMonobactams
Drug ClassMonobactam Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
AZACTAM IN PLASTIC CONTAINER
aztreonam
INJECTABLE;INJECTION050632-003May 24, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
AZACTAM IN PLASTIC CONTAINER
aztreonam
INJECTABLE;INJECTION050632-002May 24, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
AZACTAM IN PLASTIC CONTAINER
aztreonam
INJECTABLE;INJECTION050632-001May 24, 1989RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Covington
McKinsey
Daiichi Sankyo
Fish and Richardson
Cipla
Cantor Fitzgerald
Accenture
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot